Angiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance

Diabetes Obes Metab. 2003 Jul;5(4):214-22. doi: 10.1046/j.1463-1326.2003.00265.x.

Authors

E J Henriksen¹, S Jacob

Affiliation

¹ Muscle Metabolism Laboratory, Department of Physiology, University of Arizona College of Medicine, Tucson, AZ 85721-0093, USA.

PMID: 12795654
DOI: 10.1046/j.1463-1326.2003.00265.x

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Angiotensin-Converting Enzyme Inhibitors / metabolism
Angiotensin-Converting Enzyme Inhibitors / pharmacology*
Bradykinin / physiology
Glucose / metabolism
Glucose Transporter Type 4
Humans
Insulin Resistance / physiology*
Monosaccharide Transport Proteins / metabolism
Muscle Proteins*
Muscle, Skeletal / drug effects*
Nitric Oxide / physiology
Receptors, Angiotensin / physiology

Substances

Angiotensin-Converting Enzyme Inhibitors
Glucose Transporter Type 4
Monosaccharide Transport Proteins
Muscle Proteins
Receptors, Angiotensin
SLC2A4 protein, human
Nitric Oxide
Glucose
Bradykinin